Biopharmaceutical leader in the development of treatments for rare diseases
Education about the value of innovative new medicines and the Orphan Drug Act.

H.R.1231/S.456: RACE for Children Act.

H.R.2430/S.934: FDA Reauthorization Act of 2017.

Education about the 340(b)m program.

H.R.1628: American Health Care Act. Better Care Reconciliation Act and S. Better Care Reconciliation Act. Education about reimbursement for orphan drug therapies in skilled nursing facilities and proposed add-on payments in inpatient hospitals.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX